Escitalopram for the Treatment of Depression in Alzheimer's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Do-Hoon KIM, Professor
Hanlym University Hospital
Principal Investigator - Dong-Won YANG, Professor
Seoul St. Mary's Hospital
Principal Investigator - Kun-Woo PARK, Professor
Korea University Hospital
Principal Investigator - Seol-Heui HAN, Professor
Kunkuk Universicy Hospital
Principal Investigator - So-Young MUN, Professor
AJU University Hospital
Principal Investigator - Sung-Yoon KIM, Professor
Asan Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medicalexcellence
Seoul, Secho-gu Banpo-dong, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2011
- Primary completion
- 31 Jul 2014
- Completion
- 31 Jul 2014
- Last update posted
- 13 Aug 2014
- Registered enrollment
- 84
- Registry id
- NCT01841125
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.